Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8513280
APP PUB NO 20110118317A1
SERIAL NO

12923219

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is about the use of at least one epothilone or derivative thereof as an active ingredient for manufacturing a medicament for use in the treatment of disease(s) involving a neuronal connectivity defect.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE75013 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Andrieux, Annie Grenoble, FR 5 3
Höfle, Gerhard Braunschweig, DE 3 1
Job, Didier Grenoble, FR 4 3
Schweitzer, Annie Vinay, FR 2 2

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 20, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00